Skip to content
Screener

AtriCure ATRC Europe — Revenue from Contract with Customer, Excluding Assessed Tax

Other geography segments

Total International
$28.02M+9.6%
Asia Pacific
$8.63M+15.4%
Other International
$2.17M+12.1%

Similar metrics at other companies

Keysight Technologies logo
KEYSEurope — Revenue from Contract with Customer, Excluding Assessed Tax
$328M+47.1%
Ameresco logo
AMRCEurope — Revenue from Contract with Customer, Excluding Assessed Tax
$127.43M+31.8%
Mettler-Toledo International, Inc. logo
MTDEurope — Revenue from Contract with Customer, Excluding Assessed Tax
$278.69M+12.4%
AptarGroup logo
ATREurope — Revenue from Contract with Customer, Excluding Assessed Tax
$465.64M+5.2%
Jazz Pharmaceuticals logo
JAZZEurope — Revenue from Contract with Customer, Excluding Assessed Tax
$92.4M+10.5%
Brunswick logo
BCEurope — Revenue from Contract with Customer, Excluding Assessed Tax
$243.9M+7.8%

Other financials

Income statement

See full
Revenue$153.6M+12.8%
Gross profit$118.6M+16.9%
Operating income$9.7M+256%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total equity$516.4M+11.2%
Total assets$676.6M+11.1%

Cash flow

See full
Operating cash flow$22.2M+2.7%
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.01B+10.7%
Enterprise value$1.92B+7.9%
P/E770.8×
P/S3.5×-0.1×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$125,588$110,583$241,793$211,732
Europe17,20916,13333,28130,331
Asia Pacific8,6337,48415,71114,268
Other International2,1741,9394,0683,428
Total International28,01625,55653,06048,027
Total Revenue$153,604$136,139$294,853$259,759

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's europe — revenue from contract with customer, excluding assessed tax?
AtriCure (ATRC) reported europe — revenue from contract with customer, excluding assessed tax of $17.21M in Q2 2026.
How has AtriCure's europe — revenue from contract with customer, excluding assessed tax changed year-over-year?
AtriCure's europe — revenue from contract with customer, excluding assessed tax increased by 6.7% year-over-year, from $16.13M to $17.21M.
What is the long-term trend for AtriCure's europe — revenue from contract with customer, excluding assessed tax?
Over 4 years (2021 to 2025), AtriCure's europe — revenue from contract with customer, excluding assessed tax has grown at a 21.8% compound annual growth rate (CAGR), from $27.93M to $61.49M.
What does europe — revenue from contract with customer, excluding assessed tax mean?
This metric measures the total net sales generated from the sale of medical devices and therapies to customers within the European market, excluding any collected sales or value-added taxes. It serves as a primary indicator of regional market penetration, product adoption rates, and the effectiveness of the local direct sales force. Tracking this figure allows for the evaluation of geographic growth trends and the company's competitive positioning in international healthcare markets.

Ask your AI about AtriCure's europe — revenue from contract with customer, excluding assessed tax.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude